A client on hemodialysis reports feeling lightheaded and dizzy during the procedure. Which of the following actions should the nurse take first?
Increase the rate of fluid removal during dialysis.
Administer an antihypertensive medication.
Assess the client's blood pressure and pulse rate.
Elevate the client's legs to promote blood flow.
The Correct Answer is C
A) This statement is incorrect. Increasing the rate of fluid removal during dialysis may worsen the client's symptoms of lightheadedness and dizziness, as it can lead to further drops in blood pressure.
B) This statement is incorrect. Administering an antihypertensive medication is not appropriate in this situation, as the client is experiencing symptoms of low blood pressure, not high blood pressure.
C) This statement is accurate. Feeling lightheaded and dizzy during hemodialysis may be a sign of hypotension (low blood pressure), and the nurse should assess the client's blood pressure and pulse rate to determine if intervention is needed.
D) This statement is incorrect. Elevating the client's legs may promote blood flow, but it does not address the immediate issue of lightheadedness and dizziness. Assessing the client's blood pressure and pulse rate is the priority to determine the appropriate intervention.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is B
Explanation
A) This statement is incorrect. Erythropoietin-stimulating agents (ESAs) are not used to prevent infections during dialysis. They are used to address anemia by stimulating red blood cell production.
B) This statement is accurate. Erythropoietin-stimulating agents (ESAs) stimulate the bone marrow to produce more red blood cells, addressing anemia commonly associated with chronic kidney disease and dialysis.
C) This statement is incorrect. Erythropoietin-stimulating agents (ESAs) do not reduce the risk of blood clot formation. They are specific to stimulating the production of red blood cells.
D) This statement is incorrect. Erythropoietin-stimulating agents (ESAs) do not enhance kidney function and filtration. They target the production of red blood cells to address anemia associated with ESRD and dialysis.
Correct Answer is C
Explanation
A) This statement is incorrect. Serum calcium levels are not directly related to ESA therapy for anemia management. ESA therapy focuses on increasing red blood cell production.
B) This statement is incorrect. Blood urea nitrogen (BUN) levels are indicators of kidney function and may be monitored for other reasons in a client on peritoneal dialysis. However, they are not directly related to ESA therapy for anemia management.
C) This statement is accurate. During ESA therapy, the nurse should closely monitor the client's hemoglobin and hematocrit levels. ESAs stimulate the production of red blood cells and can increase hemoglobin and hematocrit levels. Regular monitoring is essential to prevent anemia or excessive increases in these values.
D) This statement is incorrect. Serum potassium levels may be monitored for a client on peritoneal dialysis due to the potential for electrolyte imbalances, but they are not the primary concern during ESA therapy for anemia management.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.